Endocrinology, Vol 108, 120-126, Copyright © 1981 by Endocrine Society

ARTICLES

The hormonal basis of reproductive defects in athymic mice: diminished gonadotropin concentrations in prepubertal females

RW Rebar, IC Morandini, GF Erickson and JE Petze

Congenitally nude athymic female mice are known to have severe deficiencies in reproductive function, including reduced ovarian weight, increased follicular atresia, decreased fertility, and premature ovarian failure, in comparison to their phenotypically normal heterozygous littermates. To determine the hormonal basis for these reproductive defects, pituitary and circulating concentrations of gonadotropins and circulating levels of gonadal steroids were quantitated in 132 congenitally athymic mice and 126 of their normal heterozygous littermates, ranging in age from 1-120 days. Although prepubertal increases in both circulating LH and FSH, which were maximal at 10 days of age, were observed in both athymic and heterozygous females, the concentrations were reduced significantly in the athymic animals (P less than 0.01). Dramatic increases in the pituitary concentrations of both LH and FSH followed at 20 days, with the concentrations in heterozygotes being 3-fold greater than those in the athymic mice (P less than 0.01 for LH; P less than 0.001 for FSH). These abnormalities in pituitary gonadotropin concentrations in the athymic mice were followed by a 2- to 3-fold reduction in the secretion of estrone but not estradiol in athymic females 30 days and older. Serum androgen levels were also reduced. From these data we infer that the reduced gonadotropin concentrations observed in the athymic animals are responsible for their increased follicular atresia and premature ovarian failure and that the thymus gland appears to be essential for normal development of the hypothalamic-pituitary-ovarian axis.

This article has been cited by other articles:

				L. F. Macedo, G. J. Sabnis, O. G. Goloubeva, and A. Brodie Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model Cancer Res., May 1, 2008; 68(9): 3516 - 3522. [Abstract] [Full Text] [PDF]

				R. G. Goya, P. C. Reggiani, S. M. Vesenbeckh, J. M. Pleau, Y. E. Sosa, G. M. Console, R. Schade, P. Henklein, and M. Dardenne Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E182 - E187. [Abstract] [Full Text] [PDF]

				M. Bielinska, E. Genova, I. Boime, H. Parviainen, S. Kiiveri, J. Leppaluoto, N. Rahman, M. Heikinheimo, and D. B. Wilson Gonadotropin-Induced Adrenocortical Neoplasia in NU/J Nude Mice Endocrinology, September 1, 2005; 146(9): 3975 - 3984. [Abstract] [Full Text] [PDF]

				D. Jelovac, G. Sabnis, B. J. Long, L. Macedo, O. G. Goloubeva, and A. M.H. Brodie Activation of Mitogen-Activated Protein Kinase in Xenografts and Cells during Prolonged Treatment with Aromatase Inhibitor Letrozole Cancer Res., June 15, 2005; 65(12): 5380 - 5389. [Abstract] [Full Text] [PDF]

				D. Jelovac, L. Macedo, O. G. Goloubeva, V. Handratta, and A. M.H. Brodie Additive Antitumor Effect of Aromatase Inhibitor Letrozole and Antiestrogen Fulvestrant in a Postmenopausal Breast Cancer Model Cancer Res., June 15, 2005; 65(12): 5439 - 5444. [Abstract] [Full Text] [PDF]

				D. Jelovac, L. Macedo, V. Handratta, B. J. Long, O. G. Goloubeva, J. N. Ingle, and A. M. H. Brodie Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model Clin. Cancer Res., November 1, 2004; 10(21): 7375 - 7381. [Abstract] [Full Text] [PDF]

				B. J. Long, D. Jelovac, V. Handratta, A. Thiantanawat, N. MacPherson, J. Ragaz, O. G. Goloubeva, and A. M. Brodie Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model J Natl Cancer Inst, March 17, 2004; 96(6): 456 - 465. [Abstract] [Full Text] [PDF]

				A. Thiantanawat, B. J. Long, and A. M. Brodie Signaling Pathways of Apoptosis Activated by Aromatase Inhibitors and Antiestrogens Cancer Res., November 15, 2003; 63(22): 8037 - 8050. [Abstract] [Full Text] [PDF]

				O. A. Brown, Y. E. Sosa, M. Dardenne, J.-M. Pléau, and R. G. Goya Studies on the Gonadotropin-Releasing Activity of Thymulin: Changes With Age J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2000; 55(4): 170B - 176. [Abstract] [Full Text]

				R. Rebar, A Miyake, T. Low, and A. Goldstein Thymosin stimulates secretion of luteinizing hormone-releasing factor Science, November 6, 1981; 214(4521): 669 - 671. [Abstract] [PDF]